<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2020000400020</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x2020000400020</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Analgésicos opioides disponíveis em Portugal aprovados para dor crónica]]></article-title>
<article-title xml:lang="en"><![CDATA[Opioid analgesics available in Portugal approved for chronic pain]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valentim Maricoto Silva]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguilar Abrantes Nogueira]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Farmácia Covilhã  ]]></institution>
<addr-line><![CDATA[Covilhã ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Farmácia Central  ]]></institution>
<addr-line><![CDATA[Caria ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>30</volume>
<numero>4</numero>
<fpage>363</fpage>
<lpage>364</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2020000400020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2020000400020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2020000400020&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO A prevalência de dor crónica na população portuguesa é de 37%, provocando limitações físicas, psicológicas, sociais e uma clara diminuição da qualidade de vida. Em alguns tipos de dor crónica, os analgésicos opioides mostraram-se como as únicas alternativas passíveis de proporcionar controlo de dor, devendo a terapêutica recorrendo a este grupo ser iniciada quando todas as outras opções falharam. Este artigo pretende rever as principais características dos analgésicos opioides, incluindo efeitos secundários e formas farmacêuticas disponíveis, tanto para terapêutica basal como de resgate.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY Chronic pain has a prevalence of 37% in the Portuguese population, causing physical limitations, psychological and social problems and a great decrease in the quality of life. In many types of chronic pain, opioid drugs are the only options that can provide pain relief, and therapy using this pharmacotherapeutic group should be started when other options have failed. This paper aims to review the main characteristics of opioid analgesics, including side effects and available pharmaceutical forms, both for baseline and rescue therapy.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Opioide]]></kwd>
<kwd lng="pt"><![CDATA[dor]]></kwd>
<kwd lng="pt"><![CDATA[analgesia]]></kwd>
<kwd lng="pt"><![CDATA[analgésico]]></kwd>
<kwd lng="pt"><![CDATA[Portugal]]></kwd>
<kwd lng="en"><![CDATA[Opioid]]></kwd>
<kwd lng="en"><![CDATA[pain]]></kwd>
<kwd lng="en"><![CDATA[analgesia]]></kwd>
<kwd lng="en"><![CDATA[analgesic]]></kwd>
<kwd lng="en"><![CDATA[Portugal]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Costa-Pereira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonça]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Lopes]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Chronic Pain: A Population-Based Nationwide Study on Its Prevalence, Characteristics and Associated Disability in Portugal]]></article-title>
<source><![CDATA[The Journal of Pain]]></source>
<year>2012</year>
<volume>13</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>773-83</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Christrup]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Drewes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Fallon]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Kress]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[McQuay]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[European Pain Federation position paper on appropriate opioid use in chronic pain management]]></article-title>
<source><![CDATA[European Journal of Pain]]></source>
<year>2017</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-19</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coluzi]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sublingual Morphine: Efficacy Reviewed]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management.]]></source>
<year>1998</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>184-92</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<source><![CDATA[Informação sobre medicamentos do INFARMED]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pathan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Basic opioid pharmacology: an update.]]></article-title>
<source><![CDATA[British Journal of Pain]]></source>
<year>2012</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Drewes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Droney]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Christrup]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Arendt-Nielsen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Differences between opioids: pharmacological, experimental, clinical and economical perspectives.]]></article-title>
<source><![CDATA[British Journal of Clinical Pharmacology]]></source>
<year>2013</year>
<volume>75</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>60-78</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katzung]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
</person-group>
<source><![CDATA[Basic &amp; Clinical Pharmacology]]></source>
<year>2004</year>
<edition>9a</edition>
<publisher-loc><![CDATA[San Francisco ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill Companies, Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wickham]]></surname>
<given-names><![CDATA[R J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer Pain Management: Opioid Analgesics, Part 2]]></article-title>
<source><![CDATA[Journal of the advanced Practitioner in Oncology]]></source>
<year>2017</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>588-607</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Treillet]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Laurent]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hadjiat]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Practical management of opioid rotation and equianalgesia]]></article-title>
<source><![CDATA[Journal of Pain Research]]></source>
<year>2018</year>
<volume>11</volume>
<page-range>2587-601</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
